Publications by authors named "Mark T Lin"

Claim this Profile
S
Single-Agent Divarasib in Patients With -Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study.
Adrian G Sacher, Wilson H Miller, Manish R Patel, Luis Paz-Ares, Armando Santoro, Mark T Lin

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.
Jayesh Desai, Guzman Alonso, Se Hyun Kim, Andres Cervantes, Thomas Karasic, Chiara Cremolini, Mark T Lin

Nat Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a G12C Mutation.
Adrian Sacher, Patricia LoRusso, Manish R Patel, Wilson H Miller, Elena Garralda, Mark T Lin

N Engl J Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-body CD8 T cell visualization before and during cancer immunotherapy: a phase 1/2 trial.
Laura Kist de Ruijter, Pim P van de Donk, Jahlisa S Hooiveld-Noeken, Danique Giesen, Sjoerd G Elias, Mark T Lin

Nat Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic polymorphisms in sepsis.
Mark T Lin, Timothy E Albertson

Crit Care Med· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis